Jinming Yu, PhD
Shandong Cancer Hospital and Institute
8
5
0
N/A
0
10
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+11 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (8)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Guangying Zhu, PhD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Worked with same sponsors:
Tingyi Xia, PhD
Chinese PLA General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Qibin Song, PhD
Renmin Hospital of Wuhan University
Shared therapeutic areas:
Worked with same sponsors:
Conghua Xie, PhD
Zhongnan Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jiancheng Li, PhD
Fujian Province Cancer Hospital
Shared therapeutic areas:
Worked with same sponsors:
Zhengfei Zhu, PhD
Fudan University
Shared therapeutic areas:
Worked with same sponsors:
Bing Lu, PhD
Cancer Hospital of Guizhou Province
Shared therapeutic areas:
Worked with same sponsors:
Zhiyong Yuan, PhD
Tianjin Medical University Cancer Institute and Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jianhua Wang, PhD
Henan Cancer Hospital
Shared therapeutic areas:
Worked with same sponsors:
Guang Li, PhD
First Hospital of China Medical University
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (8)
Showing 8 of 8 trials
Real-World Study of Iruplinalkib in the Treatment of ALK-Positive Non-Small Cell Lung Cancer
SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC
Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21
A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer
A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line Treatment
Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy
A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy.
All 8 trials loaded